Differential role of CD97 in interleukin-8-induced and granulocyte-colony stimulating factor-induced hematopoietic stem and progenitor cell mobilization

Haematologica

Volumn 93, Issue 4, 2008, Pages 601-604

  Van Pel, Melissa ^a   Hagoort, Henny ^a   Kwakkenbos, Mark J ^b   Hamann, Jörg ^b   Fibbe, Willem E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Animal models; CD97; Granulocyte colony stimulating factor; Interleukin 8; Stem cell mobilization

Indexed keywords

CD97 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD97; RECOMBINANT INTERLEUKIN 8; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CELL COMPARTMENTALIZATION; CELL FUNCTION; CELL MIGRATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; MALE; MOUSE; NEUTROPHIL; NONHUMAN; STEM CELL MOBILIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CHEMOTAXIS, LEUKOCYTE; COLONY-FORMING UNITS ASSAY; DRUG ADMINISTRATION SCHEDULE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; INTERLEUKIN-8; LEUKOCYTE COUNT; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; NEUTROPHILS; RECOMBINANT FUSION PROTEINS;

EID: 42149178419     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11606     Document Type: Article

References (19)

1. Champlin RE, Schmitz N, Horowitz MM, Chapuis B, Chopra R, Cornelissen JJ, et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Blood 2000;95:3702-9.
2. Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor 2. N Engl J Med 1992;327:99-106.
3. Bensinger WI, Price TH, Dale DC, Appelbaum FR, Clift R, Lilleby K, et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993;81:1883-8.
4. Laterveer L, Lindley IJ, Hamilton MS, Willemze R, Fibbe WE. Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. Blood 1995;85:2269-75.
5. Laterveer L, Lindley IJ, Heemskerk DP, Camps JA, Pauwels EK, Willemze R, et al. Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8. Blood 1996;87:781-8.
6. Pruijt JF, Verzaal P, van Os R, de Kruijf EJ, van Schie ML, Mantovani A, et al. Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice. Proc Natl Acad Sci USA 2002;99:6228-33.
7. Hamann J, Eichler W, Hamann D, Kerstens HM, Poddighe PJ, Hoovers JM, et al. Expression cloning and chromosomal mapping of the leukocyte activation antigen CD97, a new seven-span transmembrane molecule of the secretion receptor superfamily with an unusual extracellular domain. J Immunol 1995;155:1942-50.
8. Gray JX, Haino M, Roth MJ, Maguire JE, Jensen PN, Yarme A, et al. CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation. J Immunol 1996;157:5438-47.
9. Hamann J, van Zeventer C, Bijl A, Molenaar C, Tesselaar K,van Lier RA. Molecular cloning and characterization of mouse CD97. Int Immunol 2000;12:439-48.
10. Jaspars LH, Vos W, Aust G, van Lier RA, Hamann J. Tissue distribution of the human CD97 EGF-TM7 receptor. Tissue Antigens 2001;57:325-31.
11. Hamann J, Vogel B, van Schijndel GM,van Lier RA. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). J Exp Med 1996;184:1185-9.
12. Stacey M, Chang GW, Davies JQ, Kwakkenbos MJ, Sanderson RD, Hamann J, et al. The epidermal growth factor-like domains of the human EMR2 receptor mediate cell attachment through chondroitin sulfate glycosaminoglycans. Blood 2003;102:2916-24.
13. Leemans JC, te Velde AA, Florquin S, Bennink RJ, de Bruin K, van Lier RA, et al. The epidermal growth factor-seven transmembrane (EGF-TM7) receptor CD97 is required for neutrophil migration and host defense. J Immunol 2004;172:1125-31.
14. Lindley I, Aschauer H, Seifert JM, Lam C, Brunowsky W, Kownatzki E, et al. Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor. Proc Natl Acad Sci USA 1988;85:9199-203.
15. van Pel M, van Os R, Velders GA, Hagoort H, Heegaard PM, Lindley I, et al. Serpina1 is a potent inhibitor of IL-8-induced hematopoietic stem cell mobilization. Proc Natl Acad Sci USA 2006;103:1469-74.
16. Fibbe WE, Hamilton MS, Laterveer LL, Kibbelaar RE, Falkenburg JH, Visser JW, et al. Sustained engraftment of mice transplanted with IL-1-primed blood-derived stem cells. J Immunol 1992;148:417-21.
17. Kop EN, Adriaansen J, Smeets TJ, Vervoordeldonk MJ, van Lier RA, Hamann J, et al. CD97 neutralisation increases resistance to collagen-induced arthritis in mice. Arthritis Res Ther 2006; 8:R155.
18. Pelus LM, Bian H, King AG, Fukuda S. Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GROb/CXCL2 and GRObT/CXCL2d4. Blood 2004;103:110-9.
19. Levesque JP, Hendy J, Takamatsu Y, Williams B, Winkler IG, Simmons PJ. Mobilization by either cyclophosphamide or granulocyte colonystimulating factor transforms the bone marrow into a highly proteolytic environment. Exp Hematol 2002;30:440-9.